Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Streptococcus pneumoniae capsular polysaccharide antigen, specifically type 18C, is a serotype-specific carbohydrate structure that forms the outermost layer (capsule) of the bacterium. This capsule is a major virulence factor and plays a critical role in protecting the bacterium from host immune responses, particularly by inhibiting phagocytosis and interfering with complement-mediated clearance mechanisms. Type 18C is included among vaccine-targeted serotypes due to its role in invasive pneumococcal diseases such as pneumonia, meningitis, bacteremia, otitis media, and sinusitis. Purified type-specific polysaccharides like 18C are used for vaccine development/evaluation as well as diagnostic assays tracking epidemiology. Each capsular type has a unique repeating oligosaccharide unit structure determined by genes within the cps locus; structural diversity arises from genetic variation within these loci.
Vaccines stimulate the production of serotype-specific antibodies that opsonize bacteria and promote phagocytosis and complement-mediated killing.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae Capsular Polysaccharide Antigen (Type 18C) (CPS 18C).